CD276 and neoplasm: Thus, a number of tumor cells and CTCs (CD87+, CD87+CD117+, and CD276+CD117+ and Axl+SOX2+, EGF+SOX2+, and CD87+SOX2+) may be interesting as diagnostic markers of SCLC or indicators of dynamic disease control.